196 related articles for article (PubMed ID: 18811055)
1. Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours.
Mazurek S
Ernst Schering Found Symp Proc; 2007; (4):99-124. PubMed ID: 18811055
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S
Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate kinase type M2: a crossroad in the tumor metabolome.
Mazurek S; Grimm H; Boschek CB; Vaupel P; Eigenbrodt E
Br J Nutr; 2002 Jan; 87 Suppl 1():S23-9. PubMed ID: 11895152
[TBL] [Abstract][Full Text] [Related]
4. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.
Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
Biochem J; 2001 May; 356(Pt 1):247-56. PubMed ID: 11336658
[TBL] [Abstract][Full Text] [Related]
5. The tumor metabolome.
Mazurek S; Eigenbrodt E
Anticancer Res; 2003; 23(2A):1149-54. PubMed ID: 12820363
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase type M2 and its role in tumor growth and spreading.
Mazurek S; Boschek CB; Hugo F; Eigenbrodt E
Semin Cancer Biol; 2005 Aug; 15(4):300-8. PubMed ID: 15908230
[TBL] [Abstract][Full Text] [Related]
7. In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines.
Kumar Y; Mazurek S; Yang S; Failing K; Winslet M; Fuller B; Davidson BR
Tumour Biol; 2010 Apr; 31(2):69-77. PubMed ID: 20358419
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.
Spoden GA; Rostek U; Lechner S; Mitterberger M; Mazurek S; Zwerschke W
Exp Cell Res; 2009 Oct; 315(16):2765-74. PubMed ID: 19563799
[TBL] [Abstract][Full Text] [Related]
9. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer.
Hardt PD; Mazurek S; Toepler M; Schlierbach P; Bretzel RG; Eigenbrodt E; Kloer HU
Br J Cancer; 2004 Aug; 91(5):980-4. PubMed ID: 15266315
[TBL] [Abstract][Full Text] [Related]
10. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7.
Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
Oncogene; 2001 Oct; 20(47):6891-8. PubMed ID: 11687968
[TBL] [Abstract][Full Text] [Related]
11. Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation.
Spoden GA; Mazurek S; Morandell D; Bacher N; Ausserlechner MJ; Jansen-Dürr P; Eigenbrodt E; Zwerschke W
Int J Cancer; 2008 Jul; 123(2):312-321. PubMed ID: 18425820
[TBL] [Abstract][Full Text] [Related]
12. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.
Mazurek S; Drexler HC; Troppmair J; Eigenbrodt E; Rapp UR
Anticancer Res; 2007; 27(6B):3963-71. PubMed ID: 18225557
[TBL] [Abstract][Full Text] [Related]
13. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.
Zwerschke W; Mazurek S; Massimi P; Banks L; Eigenbrodt E; Jansen-Dürr P
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1291-6. PubMed ID: 9990017
[TBL] [Abstract][Full Text] [Related]
14. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas.
Eigenbrodt E; Basenau D; Holthusen S; Mazurek S; Fischer G
Anticancer Res; 1997; 17(4B):3153-6. PubMed ID: 9329624
[TBL] [Abstract][Full Text] [Related]
15. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
Kumar Y; Tapuria N; Kirmani N; Davidson BR
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
[TBL] [Abstract][Full Text] [Related]
16. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA
J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
[TBL] [Abstract][Full Text] [Related]
17. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.
Eigenbrodt E; Reinacher M; Scheefers-Borchel U; Scheefers H; Friis R
Crit Rev Oncog; 1992; 3(1-2):91-115. PubMed ID: 1532331
[TBL] [Abstract][Full Text] [Related]
18. Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia.
Shastri YM; Naumann M; Oremek GM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein JM
Int J Cancer; 2006 Dec; 119(11):2651-6. PubMed ID: 16929517
[TBL] [Abstract][Full Text] [Related]
19. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.
Christofk HR; Vander Heiden MG; Harris MH; Ramanathan A; Gerszten RE; Wei R; Fleming MD; Schreiber SL; Cantley LC
Nature; 2008 Mar; 452(7184):230-3. PubMed ID: 18337823
[TBL] [Abstract][Full Text] [Related]
20. Assessment of disease activity in patients with rheumatoid arthritis using plasma tumour M2-pyruvate kinase test.
Ahn SS; Kim HM; Park Y
Front Immunol; 2022; 13():901555. PubMed ID: 36059477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
